Home » Ingredients » Lactobacillus Rhamnosus
Lactobacillus Rhamnosus Benefits: What the Research Shows
Lactobacillus rhamnosus is a probiotic bacterial species, best known for the GG strain, whose effects in clinical trials depend on the strain and the condition studied. It is one of the most widely researched bacteria for supporting digestive health, immune function, and vaginal balance.
Last updated 6 October 2026
Lactobacillus Rhamnosus: the short answer
The best human evidence is for the GG strain (LGG) in preventing antibiotic-associated diarrhea, especially in children, where a meta-analysis found the risk roughly halved, though evidence quality was low to moderate. Benefits for acute diarrhea in children are small and inconsistent, and evidence for IBS, immunity, weight and mood is limited.
| What it is | A lactic acid bacterium found in the human gut and some fermented dairy foods, renamed Lacticaseibacillus rhamnosus in 2020. Effects are strain-specific: GG (LGG) is the most studied strain; others include GR-1, HN001 and CGMCC1.3724. |
|---|---|
| Most studied for | Preventing antibiotic-associated diarrhea; shortening acute diarrhea in children; preventing hospital-acquired infections in children; abdominal pain and IBS in children; vaginal health (GR-1, usually with L. reuteri RC-14); weight loss (CGMCC1.3724). |
| Amounts used in studies | LGG trials have used about 1 billion to 20 billion CFU per day: for example 1 billion CFU in fermented milk during hospital stays, 6 billion CFU twice daily in hospitalized infants, and 10 billion CFU twice daily for 5 days in acute gastroenteritis. A weight trial of CGMCC1.3724 used about 320 million CFU per day (with inulin and oligofructose) for 24 weeks. |
| Strength of evidence | Moderate: a meta-analysis found LGG cut antibiotic-associated diarrhea from 22.4% to 12.3% (clearest in children; low-to-moderate quality evidence); results for acute diarrhea are mixed, and evidence for IBS, immunity, weight and mood is limited. |
| Safety | Usually well tolerated; mild gas or bloating can occur. Rare bloodstream infections have been reported, mainly in people with central venous catheters, transplants or serious illness and in premature infants; the FDA has warned about serious infections in preterm infants given probiotics. Immunocompromised or seriously ill people should ask a doctor first. |
| In products we review | LeanBiome (Biome), Nagano Tonic, Red Boost, Finessa |
Sources: LGG antibiotic diarrhea meta-analysis · LGG acute gastroenteritis meta-analysis · 2018 NEJM LGG trial · NCCIH probiotics safety overview
Benefits of Lactobacillus Rhamnosus
What is Lactobacillus Rhamnosus?
Lactobacillus rhamnosus is a species of Gram-positive, rod-shaped bacteria that was moved in 2020 to the new genus Lacticaseibacillus (now Lacticaseibacillus rhamnosus). It is a member of the lactic acid bacteria group, which is known for converting sugars into lactic acid. While it was originally considered a subspecies of Lactobacillus casei, genetic research eventually classified it as its own distinct species. Naturally occurring in the human body, particularly within the female genitourinary tract and the digestive system, this bacterium is also found in various fermented dairy products like yogurt and specialized probiotic supplements.
A History of Discovery
The history of Lactobacillus rhamnosus is deeply tied to the discovery of the "GG" strain. In 1983, two researchers at Tufts University, Sherwood Gorbach and Barry Goldin, isolated a specific strain of L. rhamnosus from the intestinal tract of a healthy human. They were looking for a probiotic that could survive the highly acidic environment of the human stomach and successfully colonize the intestines. This strain, patented as Lactobacillus rhamnosus GG (LGG), became one of the most studied probiotic strains in the world. Since its discovery, it has been tested in many clinical trials and has become widely used in foods and dietary supplements.
Top Rated Supplements with Lactobacillus Rhamnosus
Products we review that list Lactobacillus Rhamnosus as an ingredient. Not every product discloses how much of each ingredient a serving contains, so check each review before assuming it matches the amounts used in studies.
LeanBiome, now sold as Biome by Lean for Good, is a capsule marketed for weight management through gut health. Its label lists nine probiotic species (20 billion CFU a day), a small amount of inulin, a caffeine-free green tea phytosome and two plant extracts, Sphaeranthus indicus and mangosteen rind. The combined formula has not been tested in a published trial, and the two plant extracts are at half the dose used in trials of a similar blend, so any effect on weight is unproven.
Nagano Tonic, sold as Nagano Lean Body Tonic, is a flavoured powder you stir into water or another drink once a day. Each scoop combines a greens and berry blend, nine herbs including green tea extract, ashwagandha, ginger, cinnamon and Panax ginseng, a small fibre and enzyme blend, five probiotic strains, and vitamins C and B12. It is marketed as a “Japanese elixir” that wakes up a sleeping metabolism. This review covers what the label discloses, what research on its ingredients shows at these amounts, the real package prices and how the 180-day refund works.
Red Boost is a once-a-day powder sold to men for firmer erections and blood flow, with L-citrulline, horny goat weed, maca, tongkat ali, nettle root and a fruit and beetroot blend. This review compares its label with the research and explains the prices and the 180-day refund.
Finessa is a powdered digestive supplement sold for constipation, bloating and a “flatter belly”. One scoop combines fruit and vegetable powders, liver herbs such as dandelion and milk thistle, probiotics and cascara sagrada, a stimulant laxative. This review covers what the label shows, what the research supports, why the laxative matters, side effects, the real prices and how the 180-day refund works.
Scientific Analysis of Lactobacillus Rhamnosus
The Science of Survival: Mechanism of Action
Much of what is known about how L. rhamnosus works comes from laboratory studies, mostly of the GG strain. Some strains, including GG, can survive passage through the stomach and persist for a time in the human gut, though survival varies by strain and product. Once it reaches the small and large intestines, its primary mechanism of action involves adhesion. The GG strain has hair-like appendages called SpaCBA pili that help it bind to intestinal mucus, a feature not shared by all L. rhamnosus strains. Lab studies suggest this binding may help crowd out harmful bacteria, but this has not been directly shown in people.
Competitive Exclusion and Antimicrobial Activity
Once established, L. rhamnosus engages in competitive exclusion. In lab studies, it can compete with pathogens such as E. coli and Salmonella for binding sites; whether this prevents infection in people is less clear. Furthermore, it secretes antimicrobial substances, including organic acids and bacteriocins, which lower the local pH and create an environment that is hostile to bad bacteria but favorable for beneficial flora.
Immunomodulation
Beyond simple digestion, L. rhamnosus interacts directly with the immune system. Lab and animal studies suggest it may increase secretory Immunoglobulin A (sIgA) and influence cytokine activity. These possible immune effects are why it has been studied for allergies and respiratory infections, with mixed results in people.
Health Benefits and What the Research Shows
1. Gastrointestinal Health and Diarrhea Prevention
The most studied use of L. rhamnosus GG is preventing and treating diarrhea, with results that differ by type of diarrhea. A 2019 meta-analysis found LGG shortened acute diarrhea in children by less than a day on average, but a large 2018 US trial of 943 children found no benefit. A 2015 meta-analysis found LGG cut the risk of Antibiotic-Associated Diarrhea (AAD) from 22.4% to 12.3%, mainly in children. It is thought to help by supporting gut bacteria disrupted by antibiotics, but evidence that it prevents Clostridioides difficile infection specifically is limited.
2. Irritable Bowel Syndrome (IBS) Relief
In children with IBS, a meta-analysis of three small trials found LGG modestly reduced abdominal pain; evidence in adults is limited. Effects on the intestinal barrier, sometimes described as "leaky gut," come mainly from lab studies and have not been confirmed in people.
3. Supporting the Immune System
Some trials in children suggest LGG may modestly reduce respiratory infections, but overall evidence for probiotics here is low quality. In a Finnish trial of 571 day-care children aged 1-6, those drinking LGG milk for seven months had slightly fewer sick days (4.9 vs 5.8). Evidence that it helps prevent flu or seasonal allergies in people is limited.
4. Women’s Health and Vaginal Flora
Lactobacilli help keep the vaginal environment healthy, and certain L. rhamnosus strains have been studied for this purpose. Strains such as GR-1 look promising for recurrent bacterial vaginosis, but evidence for yeast infections is unclear. By producing lactic acid, it maintains an acidic pH in the vaginal canal, which inhibits the growth of harmful fungi and bacteria.
5. Weight Management and Metabolism
Emerging research has explored the link between L. rhamnosus and weight loss. One trial of strain CGMCC1.3724 in obese adults on a diet found no overall difference, but women taking it lost more weight over 12 weeks than women on placebo. In that trial, the women's weight loss was linked to lower levels of leptin (a satiety hormone); these findings need confirming in larger studies.
Scientific Research and Clinical Trials
LGG has been studied in many trials, with results that vary by condition. A 2001 trial of 81 hospitalized infants, published in the Journal of Pediatrics, found LGG reduced nosocomial (hospital-acquired) diarrhea (6.7% vs 33.3% with placebo). A 2011 mouse study found strain JB-1 altered brain GABA receptors and reduced anxiety-like behavior, but a 2017 trial in 29 healthy men found no effect on stress or anxiety. This has fueled interest in "psychobiotics," but mental health benefits of L. rhamnosus have not been shown in people.
Potential Side Effects and Safety
Lactobacillus rhamnosus is generally well tolerated by healthy people in clinical trials. Because it is a natural inhabitant of the human body, it is generally well-tolerated. However, some individuals may experience mild side effects during the first few days of supplementation, including:
- Gas and flatulence
- Mild abdominal bloating
- Temporary changes in bowel movements
These symptoms usually subside as the body adjusts to the new microbial balance. However, individuals with severely compromised immune systems, such as those undergoing chemotherapy or those with central venous catheters, should consult a physician before use. In rare cases, probiotics have caused serious infections in vulnerable people, including premature infants.
Dosage and Recommendations
There is no standard dose, but LGG trials have mostly used about 1 billion to 20 billion Colony Forming Units (CFUs) per day. No dose has been shown to benefit healthy people for general maintenance; doses used in trials depend on the strain and condition studied. It is often found in multi-strain formulas with species like Lactobacillus acidophilus and Bifidobacterium lactis, though combinations are not proven to work better.
Frequently Asked Questions
There is little human research on the best time to take L. rhamnosus, so following the product label and taking it consistently is reasonable. Whether timing around meals changes its benefits in people has not been well studied.
Yes, in trials LGG taken during antibiotic treatment reduced antibiotic-associated diarrhea, especially in children; check with your doctor first if you are seriously ill. Separating the probiotic and antibiotic doses by a few hours is commonly advised, though the best spacing has not been well studied.
While some older formulations required refrigeration, many modern supplements use freeze-drying technology and blister packaging to make them shelf-stable. Always check the specific product label for storage instructions.
Lactobacillus rhamnosus is one of the most researched probiotics for pediatric use. In children it has been studied mainly for diarrhea; always consult a pediatrician, and do not give probiotics to premature infants without medical advice.
In trials, LGG shortened acute diarrhea in children by under a day on average, and two large 2018 trials found no benefit. For IBS, benefits seen in children's trials were modest, and how long it takes to notice changes has not been well established.
⚖️ Conclusion
Lactobacillus rhamnosus, particularly the GG strain, is one of the most studied probiotic ingredients, though good evidence exists only for some uses. Decades of research support a modest benefit for preventing antibiotic-associated diarrhea, mainly in children, while evidence for immune benefits is limited. The GG strain binds intestinal mucus well in lab studies, but this has not been shown to give longer-lasting benefits in people. The strongest evidence is for preventing antibiotic-associated diarrhea; evidence for irritable bowel syndrome is limited, and mental health benefits have not been shown in people. It is generally well tolerated by healthy people, but premature infants and seriously ill or immunocompromised people should use it only with medical advice. It is not a cure-all, and evidence that daily use protects healthy people against infections or inflammatory conditions is limited. For people considering a probiotic, it makes sense to choose a strain tested for their specific purpose, such as LGG for antibiotic-associated diarrhea. It is essential, however, to ensure potency at the time of consumption by choosing reputable brands. Overall, Lactobacillus rhamnosus GG is well studied, with modest benefits for some uses and ongoing research for others.